$SMG
SCOTTS MIRACLE-GRO CO Stock $smg

$smg Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000154638019000007 Filed on February 06, 2019

Income Statement

Concept	2017 Q4
Revenue	$221.5M
YoY Change	6.8%
Cost Of Revenue	$187.5M
YoY Change	9.91%
Gross Profit	$34.00M
YoY Change	-7.61%
Gross Profit Margin	15.35%
Selling, General & Admin	$108.2M
YoY Change	3.94%
% of Gross Profit	318.24%
Research & Development	$9.400M
YoY Change	5.62%
% of Gross Profit	27.65%
Depreciation & Amortization	$12.70M
YoY Change	-9.29%
% of Gross Profit	37.35%
Operating Expenses	$108.2M
YoY Change	3.94%
Operating Profit	-$71.90M
YoY Change	16.34%
Interest Expense	$17.80M
YoY Change	16.34%
% of Operating Profit
Other Income/Expense, Net	$2.500M
YoY Change
Pretax Income	-$86.60M
YoY Change	-4.1%
Income Tax	-$66.60M
% Of Pretax Income
Net Earnings	-$21.20M
YoY Change	-67.53%
Net Earnings / Revenue	-9.57%
Basic Earnings Per Share	-$0.37
Diluted Earnings Per Share	-$0.37
COMMON SHARES
Basic Shares Outstanding	57.60M shares
Diluted Shares Outstanding	57.60M shares

Balance Sheet

Concept	2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$54.50M
YoY Change	-25.44%
Cash & Equivalents	$54.50M
Short-Term Investments
Other Short-Term Assets	$61.70M
YoY Change	-79.87%
Inventory	$696.1M
Prepaid Expenses
Receivables	$128.4M
Other Receivables	$0.00
Total Short-Term Assets	$982.9M
YoY Change	-20.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$464.1M
YoY Change	5.96%
Goodwill	$464.8M
YoY Change	16.96%
Intangibles	$783.4M
YoY Change	6.73%
Long-Term Investments	$31.70M
YoY Change	-62.22%
Other Assets	$183.9M
YoY Change	56.24%
Total Long-Term Assets	$1.928B
YoY Change	8.86%
TOTAL ASSETS
Total Short-Term Assets	$982.9M
Total Long-Term Assets	$1.928B
Total Assets	$2.911B
YoY Change	-3.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$223.2M
YoY Change	2.2%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$86.10M
YoY Change	105.98%
Total Short-Term Liabilities	$471.1M
YoY Change	-3.97%
LONG-TERM LIABILITIES
Long-Term Debt	$1.697B
YoY Change	2.97%
Other Long-Term Liabilities	$213.0M
YoY Change	-24.28%
Total Long-Term Liabilities	$1.910B
YoY Change	-1.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$471.1M
Total Long-Term Liabilities	$1.910B
Total Liabilities	$2.403B
YoY Change	-0.7%
SHAREHOLDERS EQUITY
Retained Earnings	$925.9M
YoY Change	17.74%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$762.8M
YoY Change	55.07%
Treasury Stock Shares	10.90M shares
Shareholders Equity	$502.8M
YoY Change
Total Liabilities & Shareholders Equity	$2.911B
YoY Change	-3.37%

Cashflow Statement

Concept	2017 Q4
OPERATING ACTIVITIES
Net Income	-$21.20M
YoY Change	-67.53%
Depreciation, Depletion And Amortization	$12.70M
YoY Change	-9.29%
Cash From Operating Activities	-$210.5M
YoY Change	0.33%
INVESTING ACTIVITIES
Capital Expenditures	$19.40M
YoY Change	20.5%
Acquisitions	$70.00M
YoY Change	-10.14%
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$94.70M
YoY Change	0.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$96.20M
YoY Change	120.64%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$238.6M
YoY Change	-30.88%
NET CHANGE
Cash From Operating Activities	-$210.5M
Cash From Investing Activities	-$94.70M
Cash From Financing Activities	$238.6M
Net Change In Cash	-$66.60M
YoY Change	-260.87%
FREE CASH FLOW
Cash From Operating Activities	-$210.5M
Capital Expenditures	$19.40M
Free Cash Flow	-$229.9M
YoY Change	1.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q4	dei	Amendment Flag AmendmentFlag	false
CY2018Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2018Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2018Q4	dei	Document Period End Date DocumentPeriodEndDate	2018-12-29
CY2018Q4	dei	Document Type DocumentType	10-Q
CY2018Q4	dei	Entity Central Index Key EntityCentralIndexKey	0000825542
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55350699	shares
CY2018Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018Q4	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q4	dei	Entity Registrant Name EntityRegistrantName	SCOTTS MIRACLE-GRO CO
CY2018Q4	dei	Entity Small Business EntitySmallBusiness	false
CY2018Q4	dei	Trading Symbol TradingSymbol	SMG
CY2016Q3	smg	Additional Shares Authorized For Repurchase Value AdditionalSharesAuthorizedForRepurchaseValue	500000000.0	USD
CY2017Q4	smg	Cost Of Sales Impairment Restructuring And Other Charges CostOfSalesImpairmentRestructuringAndOtherCharges	0	USD
CY2018Q4	smg	Cost Of Sales Impairment Restructuring And Other Charges CostOfSalesImpairmentRestructuringAndOtherCharges	2500000	USD
CY2017Q4	smg	Gain Loss On Sale Of Long Lived Assets GainLossOnSaleOfLongLivedAssets	200000	USD
CY2018Q4	smg	Gain Loss On Sale Of Long Lived Assets GainLossOnSaleOfLongLivedAssets	100000	USD
CY2017Q4	smg	Gain Losson Contributionof Business GainLossonContributionofBusiness	200000	USD
CY2018Q4	smg	Gain Losson Contributionof Business GainLossonContributionofBusiness	0	USD
CY2017Q4	smg	Impairment Restructuring And Other Recoveries Charges Continuing Operations ImpairmentRestructuringAndOtherRecoveriesChargesContinuingOperations	-200000	USD
CY2018Q4	smg	Impairment Restructuring And Other Recoveries Charges Continuing Operations ImpairmentRestructuringAndOtherRecoveriesChargesContinuingOperations	6000000	USD
CY2017Q4	smg	Intercompany Assets IntercompanyAssets	0	USD
CY2018Q3	smg	Intercompany Assets IntercompanyAssets	0	USD
CY2018Q4	smg	Intercompany Assets IntercompanyAssets	0	USD
CY2018Q3	smg	Intercompany Liabilities IntercompanyLiabilities	0	USD
CY2018Q4	smg	Intercompany Liabilities IntercompanyLiabilities	0	USD
CY2017Q4	smg	Payments For Proceeds From Intercompany Advances From Financing Activities PaymentsForProceedsFromIntercompanyAdvancesFromFinancingActivities	0	USD
CY2018Q4	smg	Payments For Proceeds From Intercompany Advances From Financing Activities PaymentsForProceedsFromIntercompanyAdvancesFromFinancingActivities	0	USD
CY2018Q4	smg	Payments For Restructuring And Other PaymentsForRestructuringAndOther	4400000	USD
	smg	Percentage Of Annual Net Sales PercentageOfAnnualNetSales	0.75
	smg	Percentage Of Annual Net Sales PercentageOfAnnualNetSales	0.75
	smg	Percentage Of Annual Net Sales PercentageOfAnnualNetSales	0.75
CY2018Q4	smg	Restructuring And Other Related Charges Continuing Operations RestructuringAndOtherRelatedChargesContinuingOperations	5500000	USD
CY2017Q4	smg	Restructuring And Other Related Charges Discontinued Operations RestructuringAndOtherRelatedChargesDiscontinuedOperations	1400000	USD
CY2018Q4	smg	Restructuring And Other Related Charges Discontinued Operations RestructuringAndOtherRelatedChargesDiscontinuedOperations	-4900000	USD
CY2018Q4	smg	Restructuring And Other Related Chargesexcluding Recoveries Discontinued Operations RestructuringAndOtherRelatedChargesexcludingRecoveriesDiscontinuedOperations	100000	USD
CY2018Q4	smg	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxExpenseBenefit	-44600000	USD
CY2018Q4	smg	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit	14000000	USD
CY2018	smg	Tax Cuts And Jobs Act Of2017 Measurement Period Adjustment Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017MeasurementPeriodAdjustmentTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpenseBenefit	21200000	USD
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	8300000	shares
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	128400000	USD
CY2018Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	226000000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	163800000	USD
CY2018Q4	us-gaap	Accrual For Environmental Loss Contingencies Gross AccrualForEnvironmentalLossContingenciesGross	4200000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	602000000	USD
CY2018Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	610500000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	624000000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-68200000	USD
CY2018Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-46000000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-75300000	USD
CY2017Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	7100000	USD
CY2018Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	8300000	USD
CY2017Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6000000	USD
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6600000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2300000	USD
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3600000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3400000	USD
CY2017Q4	us-gaap	Assets Assets	2910800000	USD
CY2018Q3	us-gaap	Assets Assets	3054500000	USD
CY2018Q4	us-gaap	Assets Assets	3225200000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	982900000	USD
CY2018Q3	us-gaap	Assets Current AssetsCurrent	885700000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	1078700000	USD
CY2017Q4	smg	Total Impairment Restructuring And Other Charges TotalImpairmentRestructuringAndOtherCharges	1200000	USD
CY2018Q4	smg	Total Impairment Restructuring And Other Charges TotalImpairmentRestructuringAndOtherCharges	1100000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	223200000	USD
CY2018Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	150500000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	237000000	USD
CY2017Q4	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1300000	USD
CY2017Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	300000	USD
CY2018Q4	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3200000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	120500000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54500000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33900000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22600000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-66000000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-11300000	USD
CY2017Q4	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
CY2018Q4	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	0	USD
CY2017Q4	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1400000	USD
CY2018Q4	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	1800000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.530
CY2018Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.550
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57200000	shares
CY2018Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55300000	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55300000	shares
CY2017Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	407900000	USD
CY2018Q3	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	420300000	USD
CY2018Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	425900000	USD
CY2017Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20200000	USD
CY2018Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-92000000	USD
CY2017Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2018Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-100000	USD
CY2017Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-20200000	USD
CY2018Q4	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-92100000	USD
CY2017Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	187500000	USD
CY2018Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	261100000	USD
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1791300000	USD
CY2018Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2025700000	USD
CY2018Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2290200000	USD
CY2018Q4	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2017Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.047
CY2018Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.048
CY2017Q4	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-47600000	USD
CY2018Q4	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1300000	USD
CY2017Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	157500000	USD
CY2017Q4	us-gaap	Depreciation Depreciation	12700000	USD
CY2018Q4	us-gaap	Depreciation Depreciation	14000000	USD
CY2018Q3	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	11000000	USD
CY2018Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	-3400000	USD
CY2017Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	-1200000	USD
CY2018Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	4900000	USD
CY2017Q4	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
CY2018Q4	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	2000000	USD
CY2017Q4	us-gaap	Dividends Dividends	31100000	USD
CY2018Q4	us-gaap	Dividends Dividends	30900000	USD
CY2017Q4	us-gaap	Due To Affiliate Noncurrent DueToAffiliateNoncurrent	21900000	USD
CY2018Q3	us-gaap	Due To Affiliate Noncurrent DueToAffiliateNoncurrent	21900000	USD
CY2018Q4	us-gaap	Due To Affiliate Noncurrent DueToAffiliateNoncurrent	21900000	USD
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.44
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.44
CY2017Q4	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	600000	USD
CY2018Q4	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-700000	USD
CY2017Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.769
CY2018Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.220
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.245
CY2017Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2300000	USD
CY2018Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1700000	USD
CY2017Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	0	USD
CY2018Q3	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	0	USD
CY2018Q4	us-gaap	Equity Method Investment Underlying Equity In Net Assets EquityMethodInvestmentUnderlyingEquityInNetAssets	0	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	31700000	USD
CY2018Q3	us-gaap	Equity Method Investments EquityMethodInvestments	36100000	USD
CY2018Q4	us-gaap	Equity Method Investments EquityMethodInvestments	37300000	USD
CY2017Q4	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	200000	USD
CY2018Q4	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2017Q4	us-gaap	Goodwill Goodwill	464800000	USD
CY2018Q3	us-gaap	Goodwill Goodwill	543000000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	539700000	USD
CY2017Q4	us-gaap	Gross Profit GrossProfit	34000000	USD
CY2018Q4	us-gaap	Gross Profit GrossProfit	34500000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-86600000	USD
CY2018Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-105900000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-20000000	USD
CY2018Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-82600000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.35
CY2018Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.49
CY2017Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.35
CY2018Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.49
CY2017Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1200000	USD
CY2018Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	2900000	USD
CY2017Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.02
CY2018Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.05
CY2017Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.02
CY2018Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.05
CY2017Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	600000	USD
CY2018Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8100000	USD
CY2018Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	8300000	USD
CY2018Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	1300000	USD
CY2017Q4	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	600000	USD
CY2018Q4	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	1300000	USD
CY2017Q4	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	0	USD
CY2018Q4	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	0	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-66600000	USD
CY2018Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-23300000	USD
CY2018	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	18200000	USD
CY2018Q4	us-gaap	Income Tax Reconciliation Tax Credits Foreign IncomeTaxReconciliationTaxCreditsForeign	13900000	USD
CY2017Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1500000	USD
CY2018Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	8700000	USD
CY2017Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	84000000	USD
CY2018Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	93100000	USD
CY2017Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-117600000	USD
CY2018Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-100700000	USD
CY2017Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	282700000	USD
CY2018Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	267100000	USD
CY2017Q4	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-83300000	USD
CY2018Q4	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-58700000	USD
CY2017Q4	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	5200000	USD
CY2018Q4	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	1600000	USD
CY2017Q4	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	400000	USD
CY2018Q4	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-400000	USD
CY2017Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6300000	USD
CY2018Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	48400000	USD
CY2017Q4	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	-2800000	USD
CY2018Q4	us-gaap	Increase Decrease In Restructuring Reserve IncreaseDecreaseInRestructuringReserve	1200000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	783400000	USD
CY2018Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	857300000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	846800000	USD
CY2017Q4	us-gaap	Interest Expense InterestExpense	17800000	USD
CY2018Q4	us-gaap	Interest Expense InterestExpense	25200000	USD
CY2017Q4	us-gaap	Interest Paid Net InterestPaidNet	25500000	USD
CY2018Q4	us-gaap	Interest Paid Net InterestPaidNet	31400000	USD
CY2017Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	462300000	USD
CY2018Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	292100000	USD
CY2018Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	524300000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	696100000	USD
CY2018Q3	us-gaap	Inventory Net InventoryNet	481400000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	745400000	USD
CY2017Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	162800000	USD
CY2018Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	129200000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	147300000	USD
CY2017Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	11400000	USD
CY2017Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	71000000	USD
CY2018Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	60100000	USD
CY2018Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	73800000	USD
CY2017Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2018Q3	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2018Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2017Q4	us-gaap	Liabilities Liabilities	2403000000	USD
CY2018Q3	us-gaap	Liabilities Liabilities	2694900000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	2972000000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2910800000	USD
CY2018Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3054500000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3225200000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	471100000	USD
CY2018Q3	us-gaap	Liabilities Current LiabilitiesCurrent	612700000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	594600000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	86100000	USD
CY2018Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	132600000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	95100000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1697000000	USD
CY2018Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1883800000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2186200000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	5000000	USD
CY2018Q3	us-gaap	Minority Interest MinorityInterest	5000000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	4900000	USD
CY2017Q4	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	13600000	USD
CY2017Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	238600000	USD
CY2018Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	239900000	USD
CY2017Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-94700000	USD
CY2018Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17100000	USD
CY2017Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-210500000	USD
CY2018Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-233400000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-21200000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-79600000	USD
CY2017Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2018Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-100000	USD
CY2018Q4	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification	9100000	USD
CY2018Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-71900000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-84900000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	183900000	USD
CY2018Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	201600000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	202900000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	700000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-8000000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5300000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1000000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-12400000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-12400000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-300000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-900000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Before Reclassification Adjustments Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax	200000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Before Reclassification Adjustments Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax	300000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	100000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	100000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax	-100000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax	0	USD
CY2017Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax	300000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax	900000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	800000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-7900000	USD
CY2017Q4	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	500000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	-2800000	USD
CY2017Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	161800000	USD
CY2018Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	329600000	USD
CY2018Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	262500000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	213000000	USD
CY2018Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	176500000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	169300000	USD
CY2017Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2500000	USD
CY2018Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2900000	USD
CY2017Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	2100000	USD
CY2018Q4	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	400000	USD
CY2017Q4	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	0	USD
CY2018Q4	us-gaap	Payments For Proceeds From Businesses And Interest In Affiliates PaymentsForProceedsFromBusinessesAndInterestInAffiliates	0	USD
CY2017Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2018Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-2200000	USD
CY2017Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	96200000	USD
CY2018Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	500000	USD
CY2017Q4	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	70100000	USD
CY2018Q4	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	USD
CY2017Q4	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	30500000	USD
CY2018Q4	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	30400000	USD
CY2017Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	70000000	USD
CY2018Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	6600000	USD
CY2017Q4	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	5300000	USD
CY2018Q4	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	0	USD
CY2017Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19400000	USD
CY2018Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12700000	USD
CY2017Q4	us-gaap	Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue	42200000	USD
CY2018Q3	us-gaap	Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue	84500000	USD
CY2018Q4	us-gaap	Pledged Assets Separately Reported Finance Receivables Pledged As Collateral At Fair Value PledgedAssetsSeparatelyReportedFinanceReceivablesPledgedAsCollateralAtFairValue	44400000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	61700000	USD
CY2018Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	59900000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	102500000	USD
CY2017Q4	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	USD
CY2018Q4	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	USD
CY2017Q4	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	573400000	USD
CY2018Q4	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	386800000	USD
CY2017Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000000	USD
CY2018Q4	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1100000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	-21200000	USD
CY2018Q4	us-gaap	Profit Loss ProfitLoss	-79700000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	464100000	USD
CY2018Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	530800000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	519800000	USD
CY2017Q4	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	136000000	USD
CY2018Q4	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	116300000	USD
CY2017Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3000000	USD
CY2018Q4	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	800000	USD
CY2017Q4	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	0	USD
CY2018Q4	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	500000	USD
CY2018Q3	us-gaap	Restructuring Reserve RestructuringReserve	112200000	USD
CY2018Q4	us-gaap	Restructuring Reserve RestructuringReserve	113400000	USD
CY2018Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	2000000	USD
CY2017Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	-200000	USD
CY2018Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	3500000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	925900000	USD
CY2018Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	919900000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	835400000	USD
CY2017Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	221500000	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	298100000	USD
CY2017Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	108200000	USD
CY2018Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	116300000	USD
CY2017Q4	us-gaap	Share Based Compensation ShareBasedCompensation	6000000	USD
CY2018Q4	us-gaap	Share Based Compensation ShareBasedCompensation	6600000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	210065.000000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	5099.000000	shares
CY2017Q4	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	20600000	USD
CY2018Q4	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	400000	USD
CY2017Q4	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	1600000	USD
CY2018Q4	us-gaap	Stock Issued During Period Value Treasury Stock Reissued StockIssuedDuringPeriodValueTreasuryStockReissued	900000	USD
CY2014Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	500000000.0	USD
CY2016Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	1000000000	USD
CY2014Q3	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P5Y
CY2017Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1000000	shares
CY2018Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	714600000	USD
CY2017Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	96600000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	502800000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	354600000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	248300000	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	661700000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	507800000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	359600000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	253200000	USD
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	10900000	shares
CY2018Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	12800000	shares
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	12800000	shares
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	762800000	USD
CY2018Q3	us-gaap	Treasury Stock Value TreasuryStockValue	939600000	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	937700000	USD
CY2017Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	96600000	USD
CY2017Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8200000	USD
CY2018Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	9300000	USD
CY2018Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	8900000	USD
CY2018Q3	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	97800000	USD
CY2018	us-gaap	Valuation Allowances And Reserves Charged To Cost And Expense ValuationAllowancesAndReservesChargedToCostAndExpense	500000	USD
CY2017Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57600000	shares
CY2018Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55300000	shares
CY2017Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57600000	shares
CY2018Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55300000	shares
CY2018Q4	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">CONTINGENCIES</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Management regularly evaluates the Company’s contingencies, including various lawsuits and claims which arise in the normal course of business, product and general liabilities, workers’ compensation, property losses and other liabilities for which the Company is self-insured or retains a high exposure limit. Self-insurance accruals are established based on actuarial loss estimates for specific individual claims plus actuarially estimated amounts for incurred but not reported claims and adverse development factors applied to existing claims. Legal costs incurred in connection with the resolution of claims, lawsuits and other contingencies generally are expensed as incurred. In the opinion of management, the assessment of contingencies is reasonable and related accruals, in the aggregate, are adequate; however, there can be no assurance that final resolution of these matters will not have a material effect on the Company’s financial condition, results of operations or cash flows. </font></div><div style="line-height:120%;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Regulatory Matters</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 29, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$4.2 million</font><font style="font-family:inherit;font-size:10pt;"> was accrued in the “Other liabilities” line in the Condensed Consolidated Balance Sheet for environmental actions, the majority of which are for site remediation. The amounts accrued are believed to be adequate to cover such known environmental exposures based on current facts and estimates of likely outcomes. Although it is reasonably possible that the costs to resolve such known environmental exposures will exceed the amounts accrued, any variation from accrued amounts is not expected to be material.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-decoration:underline;">Other</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has been named as a defendant in a number of cases alleging injuries that the lawsuits claim resulted from exposure to asbestos-containing products, apparently based on the Company’s historic use of vermiculite in certain of its products. In many of these cases, the complaints are not specific about the plaintiffs’ contacts with the Company or its products. The cases vary, but complaints in these cases generally seek unspecified monetary damages (actual, compensatory, consequential and punitive) from multiple defendants. The Company believes that the claims against it are without merit and is vigorously defending against them. No accruals have been recorded in the Company’s consolidated financial statements as the likelihood of a loss is not probable at this time; and the Company does not believe a reasonably possible loss would be material to, nor the ultimate resolution of these cases will have a material adverse effect on, the Company’s financial condition, results of operations or cash flows. There can be no assurance that future developments related to pending claims or claims filed in the future, whether as a result of adverse outcomes or as a result of significant defense costs, will not have a material effect on the Company’s financial condition, results of operations or cash flows. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In connection with the sale of wild bird food products that were the subject of a voluntary recall in 2008, the Company, along with its Chief Executive Officer, have been named as defendants in four actions filed on and after June 27, 2012, which have been consolidated, and, on March 31, 2017, certified as a class action in the United States District Court for the Southern District of California as </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">In re Morning Song Bird Food Litigation</font><font style="font-family:inherit;font-size:10pt;">, Lead Case No. 3:12-cv-01592-JAH-AGS. The plaintiffs allege various statutory and common law claims associated with the Company’s sale of wild bird food products and a plea agreement entered into in previously pending government proceedings associated with such sales. The plaintiffs allege, among other things, a class action on behalf of all persons and entities in the United States who purchased certain bird food products. The plaintiffs assert: (i) hundreds of millions of dollars in monetary damages (actual, compensatory, consequential, and restitution); (ii) punitive and treble damages; (iii) injunctive and declaratory relief; (iv) pre-judgment and post-judgment interest; and (v) costs and attorneys’ fees. The Company and its Chief Executive Officer dispute the plaintiffs’ assertions and have vigorously defended the consolidated action. The parties reached an agreement to settle this matter, which the parties memorialized in a settlement agreement submitted to the Court for approval on December 7, 2018. On January 31, 2019, the Court preliminarily approved the settlement, and scheduled a final fairness hearing for June 3, 2019. At </font><font style="font-family:inherit;font-size:10pt;">December 29, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$85.0 million</font><font style="font-family:inherit;font-size:10pt;"> was accrued for a probable loss related to this matter in the “Other current liabilities” line in the Condensed Consolidated Balance Sheet. During the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;">December 29, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company recognized insurance recoveries of </font><font style="font-family:inherit;font-size:10pt;">$5.0 million</font><font style="font-family:inherit;font-size:10pt;"> related to this matter in the “Income (loss) from discontinued operations, net of tax” line in the Condensed Consolidated Statements of Operations. There can be no assurance that future developments with respect to this action, whether as a result of an adverse outcome or as a result of significant defense costs, will not have a material adverse effect on the Company’s financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company was named as a defendant in </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">In re Scotts EZ Seed Litigation</font><font style="font-family:inherit;font-size:10pt;">, Case No. 12-cv-4727 (VB), a New York and California class action lawsuit filed August 9, 2012 in the United States District Court for the Southern District of New York that asserted claims under false advertising and other legal theories based on a marketing statement on the Company’s EZ Seed grass seed product from 2009 to 2012. The plaintiffs sought, on behalf of themselves and purported class members, various forms of monetary and non-monetary relief, including statutory damages that they contend could amount to hundreds of millions of dollars. The Company defended the action vigorously, and disputed the plaintiffs’ claims and theories, including the recoverability of statutory damages. In 2017, the Court eliminated certain claims, narrowed the case in certain respects, and permitted the case to continue proceeding as a class action. On August 7, 2017, the Court requested briefs on the Company’s request for interlocutory review of issues relating to the recoverability of statutory damages in a class action by the United States Court of Appeals for the Second Circuit and, on August 31, 2017, approved that request. On January 8, 2018, however, the Second Circuit denied the interlocutory appeal request. The parties engaged in mediation on April 9, 2018 and agreed in principle to a preliminary settlement of the outstanding claims on April 10, 2018. The preliminary settlement required the Company to pay certain attorneys’ and administrative fees and provide certain payments to the class members. The preliminary settlement was approved by the court on December 19, 2018, and this case is now resolved, pending the final payment of the claims made by class members (which is currently underway and should conclude by February 28, 2019). At </font><font style="font-family:inherit;font-size:10pt;">December 29, 2018</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$12.2 million</font><font style="font-family:inherit;font-size:10pt;"> was accrued for a probable loss related to this matter in the “Other current liabilities” line in the Condensed Consolidated Balance Sheet. During the three months ended </font><font style="font-family:inherit;font-size:10pt;">December 29, 2018</font><font style="font-family:inherit;font-size:10pt;">, the Company recognized a charge of </font><font style="font-family:inherit;font-size:10pt;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> for a probable loss related to this matter in the “Impairment, restructuring and other” line in the Condensed Consolidated Statements of Operations. The resolution of the claims process may result in additional losses in excess of the amount accrued, however, the Company does not believe a reasonably possible loss in excess of the amount accrued would be material to, nor have a material adverse effect on, the Company’s financial condition, results of operations or cash flows.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is involved in other lawsuits and claims which arise in the normal course of business. These claims individually and in the aggregate are not expected to result in a material effect on the Company’s financial condition, results of operations or cash flows.</font></div></div>

Files In Submission

Name	View Source	Status
0001546380-19-000007-index-headers.html	Edgar Link	pending
0001546380-19-000007-index.html	Edgar Link	pending
0001546380-19-000007.txt	Edgar Link	pending
0001546380-19-000007-xbrl.zip	Edgar Link	pending
exhibit21smg12292018q1f19.htm	Edgar Link	pending
exhibit311smg12292018q1f19.htm	Edgar Link	pending
exhibit312smg12292018q1f19.htm	Edgar Link	pending
exhibit32smg12292018q1f19.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
smg-1229201810xq1.htm	Edgar Link	pending
smg-20181229.xml	Edgar Link	completed
smg-20181229.xsd	Edgar Link	pending
smg-20181229_cal.xml	Edgar Link	unprocessable
smg-20181229_def.xml	Edgar Link	unprocessable
smg-20181229_lab.xml	Edgar Link	unprocessable
smg-20181229_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SMG
SCOTTS MIRACLE-GRO CO Stock $smg

2017 Q4 Form 10-Q Financial Statement

#000154638019000007 Filed on February 06, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SMG SCOTTS MIRACLE-GRO CO Stock $smg

2017 Q4 Form 10-Q Financial Statement

#000154638019000007 Filed on February 06, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SMG
SCOTTS MIRACLE-GRO CO Stock $smg